Back to Search
MOHAMMED ABDELRAHIM, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1922746320Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method.
PMID 19392586·J Aerosol Med Pulm Drug Deliv·2009
8-other
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
PMID 19582879·Int J Cancer·2009
7-preclinical
Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2.
PMID 19602668·J Leukoc Biol·2009
7-preclinical
The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
PMID 19435870·Mol Cancer Ther·2009
7-preclinical
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
PMID 19406933·Carcinogenesis·2009
7-preclinical
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
PMID 19258429·Mol Cancer Ther·2009
7-preclinical
5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.
PMID 18645021·Mol Cancer Ther·2008
7-preclinical
Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes.
PMID 18852139·Mol Cancer Ther·2008
8-other
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
PMID 18460448·Carcinogenesis·2008
7-preclinical
Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.
PMID 18006642·Mol Endocrinol·2008
8-other
1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
PMID 17957723·Mol Carcinog·2008
8-other
Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
PMID 17234778·Cancer Res·2007
7-preclinical
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
PMID 18006776·Clin Cancer Res·2007
7-preclinical
Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
PMID 17409437·Cancer Res·2007
8-other
Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins.
PMID 16574784·Endocrinology·2006
8-other
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
PMID 16985067·Mol Cancer Ther·2006
7-preclinical
Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells.
PMID 16972788·Biol Chem·2006
8-other
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
PMID 16788159·J Natl Cancer Inst·2006
7-preclinical
Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
PMID 16678129·Biochem Biophys Res Commun·2006
8-other
Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells.
PMID 16505105·Mol Cancer Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- LOMA LINDA UNIVERSITY HEALTH- INTERNAL MEDICINE, 11234 ANDERSON STREET
LOMA LINDA, CA 92354 - Phone
- (909) 558-4074
Quick Facts
- NPI
- 1922746320
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile